课题基金 / 基金详情

HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY

HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY
基于高通量生物标志物的生物剂量测定
批准号:
9915374
负责人:
GEORGE SIGAL
金额:
$73.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-15 至 2020-03-14

项目摘要

项目成果

GEORGE SIGAL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of the program is to develop a high throughput biodosimetry test suitable for use in mass casualty situations following a radiological/nuclear incident. The device, the UHT Biodosimetry Test, will quantitate six blood biomarkers in patient plasma samples using multiplexed immunoassays and apply a multi-parameter algorithm to estimate absorbed radiation dose. The radiation markers have been developed and tested during MSD’s on-going biodosimetry program to develop a triage test
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY
  • 批准号:
    10382187
  • 项目类别:
  • 资助金额:
    $11.29万
  • 财政年份:
    2017
  • 负责人:
    GEORGE SIGAL
  • 依托单位:
COVID 19 Supplemental work: HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY
  • 批准号:
    10260009
  • 项目类别:
  • 资助金额:
    $149.97万
  • 财政年份:
    2017
  • 负责人:
    GEORGE SIGAL
  • 依托单位:
海外基金